RJF vs STXS · rev $15.91B vs rev $14.0M
RJF (RJF) versus Stereotaxis Inc (STXS) — a side-by-side from cached financials, not a winner call.
RJF (RJF) common stock.
Stereotaxis Inc (STXS) is a medical instruments & supplies company listed on AMEX.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
Latest reported STXS revenue for 2026-06-30 was $14.0M. Net income was -$10.3M. STXS currently screens at market cap $174.0M.
RJF currently screens at market cap $0. STXS currently screens at market cap $174.0M.
Not investment advice. Open the RJF and STXS stock pages for the full models.
Not investment advice.